This is a routine conference attendance filing with no new data or catalysts. Traders should not expect any stock price reaction. Monitor upcoming catalyst timelines for lacutamab, IPH4502, and potential partnership updates as the primary value drivers.
Price Chart
Executive Summary
Innate Pharma announced its executive team will participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference on June 24, 2026, in New York. This is a routine investor engagement event with no material financial or clinical data disclosed, offering limited standalone impact.
Key Facts
- Innate Pharma to attend Jefferies Global Healthcare Conference on June 24, 2026, in New York.
- Executive team will hold one-on-one investor meetings only — no formal presentation or new data disclosed.
- No material financial, clinical, or partnership information released.
- Prior 20-F filing (April 1, 2026) highlighted a funding gap and going-concern risk beyond Q3 2026 cash runway.
Financial Impact
No financial figures disclosed in this filing.
Risk Factors
- No new clinical data or financial updates — conference participation alone is not a catalyst.
- Limited cash runway (into Q3 2026 per prior 20-F) increases financing risk before late 2026.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-036122 |
| Document: a260519_6k.htm | 0001628280-26-036122 |
| Document: 0001628280-26-036122-index-headers.html | 0001628280-26-036122 |
| Document: 0001628280-26-036122-index.html | 0001628280-26-036122 |
| Document: 0001628280-26-036122.txt | 0001628280-26-036122 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 19, 2026 22w ago | 6-K | $2.25 $1.65 | ▼ −26.67% | ▼ −32.96% | $1.51 (−32.93%) |
May 13, 2026 23w ago | 6-K | $1.50 $1.65 | ▼ −10.00% | ▼ −5.56% | $1.51 (−0.60%) |
May 6, 2026 24w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +7.94% | $1.51 (+0.60%) |
Apr 23, 2026 26w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +4.98% | $1.51 (+0.60%) |
Apr 17, 2026 27w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +3.86% | $1.51 (+0.60%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 8, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +9.72% | $1.51 (+9.91%) |
Apr 3, 2026 29w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +6.71% | $1.51 (+9.91%) |
Apr 1, 2026 29w ago | 20-F | $1.37 $1.65 | ▼ −20.17% | ▼ −6.80% | $1.51 (−9.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers